DC Field | Value | Language |
---|---|---|
dc.contributor.author | H Park | - |
dc.contributor.author | S Y Kim | - |
dc.contributor.author | A Kyung | - |
dc.contributor.author | Tae-Sung Yoon | - |
dc.contributor.author | S E Ryu | - |
dc.contributor.author | Dae Gwin Jeong | - |
dc.date.accessioned | 2017-04-19T09:27:34Z | - |
dc.date.available | 2017-04-19T09:27:34Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | 10.1016/j.bmcl.2011.10.083 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/10503 | - |
dc.description.abstract | Dual-specificity protein tyrosine phosphatase localized to mitochondrion 1 (PTPMT1) has recently proved to be a promising therapeutic target for the treatment of type II diabetes. Herein we report the first example for a successful application of the structure-based virtual screening to identify the novel inhibitors of human PTPMT1. These inhibitors were computationally screened for having desirable physicochemical properties as a drug candidate and reveal a high potency with IC 50 values ranging from 0.7 to 17.3 μM. Therefore, they deserve consideration for further development by structure-activity relationship studies to optimize the antidiabetic activities. Structural features relevant to the stabilization of the newly identified inhibitors in the active site of PTPMT1 are addressed in detail. | - |
dc.publisher | Elsevier | - |
dc.title | Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors = PTPMT1 탈인산화효소의 저해제 개발을 위한 구조기반 가상검색 | - |
dc.title.alternative | Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors | - |
dc.type | Article | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.number | 2 | - |
dc.citation.endPage | 1275 | - |
dc.citation.startPage | 1271 | - |
dc.citation.volume | 22 | - |
dc.contributor.affiliatedAuthor | Tae-Sung Yoon | - |
dc.contributor.affiliatedAuthor | Dae Gwin Jeong | - |
dc.contributor.alternativeName | 박황서 | - |
dc.contributor.alternativeName | 김송이 | - |
dc.contributor.alternativeName | 경아영 | - |
dc.contributor.alternativeName | 윤태성 | - |
dc.contributor.alternativeName | 류성언 | - |
dc.contributor.alternativeName | 정대균 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 2, pp. 1271-1275 | - |
dc.identifier.doi | 10.1016/j.bmcl.2011.10.083 | - |
dc.subject.keyword | Antidiabetic agents | - |
dc.subject.keyword | Docking | - |
dc.subject.keyword | Inhibitor | - |
dc.subject.keyword | PTPMT1 | - |
dc.subject.keyword | Virtual screening | - |
dc.subject.local | Antidiabetic agents | - |
dc.subject.local | docking | - |
dc.subject.local | Docking | - |
dc.subject.local | inhibitors | - |
dc.subject.local | Inhibitors | - |
dc.subject.local | inhibitor | - |
dc.subject.local | Inhibitor | - |
dc.subject.local | PTPMT1 | - |
dc.subject.local | Virtual screening | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.